iShares US Pharmaceuticals ETF
IHE
IHE
101 hedge funds and large institutions have $139M invested in iShares US Pharmaceuticals ETF in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 41 reducing their positions, and 16 closing their positions.
Holders
101
Holders Change
-7
Holders Change %
-6.48%
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
17
Reduced
41
Closed
16
Calls
$1.05M
Puts
$605K
Net Calls
+$443K
Net Calls Change
+$150K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$41.5M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$4.74M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$5.83M |
| 4 |
SB
4
Suntrust Banks
Atlanta,
Georgia
|
$415K |
| 5 |
RJA
5
Raymond James & Associates
St Petersburg,
Florida
|
$3.58M |
